300 related articles for article (PubMed ID: 17562560)
1. Synthesis and structure-activity relationships of 3H-quinazolin-4-ones and 3H-pyrido[2,3-d]pyrimidin-4-ones as CXCR3 receptor antagonists.
Storelli S; Verzijl D; Al-Badie J; Elders N; Bosch L; Timmerman H; Smit MJ; De Esch IJ; Leurs R
Arch Pharm (Weinheim); 2007 Jun; 340(6):281-91. PubMed ID: 17562560
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG
J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationship of 3-phenyl-3H-quinazolin-4-one derivatives as CXCR3 chemokine receptor antagonists.
Storelli S; Verdijk P; Verzijl D; Timmerman H; van de Stolpe AC; Tensen CP; Smit MJ; De Esch IJ; Leurs R
Bioorg Med Chem Lett; 2005 Jun; 15(11):2910-3. PubMed ID: 15911279
[TBL] [Abstract][Full Text] [Related]
4. Noncompetitive antagonism and inverse agonism as mechanism of action of nonpeptidergic antagonists at primate and rodent CXCR3 chemokine receptors.
Verzijl D; Storelli S; Scholten DJ; Bosch L; Reinhart TA; Streblow DN; Tensen CP; Fitzsimons CP; Zaman GJ; Pease JE; de Esch IJ; Smit MJ; Leurs R
J Pharmacol Exp Ther; 2008 May; 325(2):544-55. PubMed ID: 18270317
[TBL] [Abstract][Full Text] [Related]
5. Optimization of a series of quinazolinone-derived antagonists of CXCR3.
Liu J; Fu Z; Li AR; Johnson M; Zhu L; Marcus A; Danao J; Sullivan T; Tonn G; Collins T; Medina J
Bioorg Med Chem Lett; 2009 Sep; 19(17):5114-8. PubMed ID: 19632842
[TBL] [Abstract][Full Text] [Related]
6. Discovery and optimization of a series of quinazolinone-derived antagonists of CXCR3.
Johnson M; Li AR; Liu J; Fu Z; Zhu L; Miao S; Wang X; Xu Q; Huang A; Marcus A; Xu F; Ebsworth K; Sablan E; Danao J; Kumer J; Dairaghi D; Lawrence C; Sullivan T; Tonn G; Schall T; Collins T; Medina J
Bioorg Med Chem Lett; 2007 Jun; 17(12):3339-43. PubMed ID: 17448658
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of quinazolin-4(3H)-ones via amidine N-arylation.
Li B; Samp L; Sagal J; Hayward CM; Yang C; Zhang Z
J Org Chem; 2013 Feb; 78(3):1273-7. PubMed ID: 23289853
[TBL] [Abstract][Full Text] [Related]
8. Development of 2-aryl substituted quinazolin-4(3H)-one, pyrido[4,3-d]pyrimidin-4(3H)-one and pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as microsomal prostaglandin E(2) synthase-1 inhibitors.
Banerjee A; Pawar MY; Patil S; Yadav PS; Kadam PA; Kattige VG; Deshpande DS; Pednekar PV; Pisat MK; Gharat LA
Bioorg Med Chem Lett; 2014 Oct; 24(20):4838-44. PubMed ID: 25260492
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-inflammatory activity of newer quinazolin-4-one derivatives.
Kumar A; Rajput CS
Eur J Med Chem; 2009 Jan; 44(1):83-90. PubMed ID: 18501478
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and application of the first radioligand targeting the allosteric binding pocket of chemokine receptor CXCR3.
Bernat V; Heinrich MR; Baumeister P; Buschauer A; Tschammer N
ChemMedChem; 2012 Aug; 7(8):1481-9. PubMed ID: 22689503
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity of some 2, 3-disubstituted quinazolin-4(3H)-ones and 4, 6- disubstituted- 1, 2, 3, 4-tetrahydroquinazolin-2H-ones.
Abdel Gawad NM; Georgey HH; Youssef RM; El-Sayed NA
Eur J Med Chem; 2010 Dec; 45(12):6058-67. PubMed ID: 21051122
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR studies of novel 2-(6-aminomethylaryl-2-aryl-4-oxo-quinazolin-3(4H)-yl)acetamide vasopressin V1b receptor antagonists.
Napier SE; Letourneau JJ; Ansari N; Auld DS; Baker J; Best S; Campbell-Wan L; Chan R; Craighead M; Desai H; Ho KK; MacSweeney C; Milne R; Richard Morphy J; Neagu I; Ohlmeyer MH; Pick J; Presland J; Riviello C; Zanetakos HA; Zhao J; Webb ML
Bioorg Med Chem Lett; 2011 Jun; 21(12):3813-7. PubMed ID: 21596563
[TBL] [Abstract][Full Text] [Related]
13. An inhibitory metabolite leads to dose- and time-dependent pharmacokinetics of (R)-N-{1-[3-(4-ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3-d]pyrimidin-2-yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in human subjects after multiple dosing.
Tonn GR; Wong SG; Wong SC; Johnson MG; Ma J; Cho R; Floren LC; Kersey K; Berry K; Marcus AP; Wang X; Van Lengerich B; Medina JC; Pearson PG; Wong BK
Drug Metab Dispos; 2009 Mar; 37(3):502-13. PubMed ID: 19088267
[TBL] [Abstract][Full Text] [Related]
14. Identification of overlapping but differential binding sites for the high-affinity CXCR3 antagonists NBI-74330 and VUF11211.
Scholten DJ; Roumen L; Wijtmans M; Verkade-Vreeker MC; Custers H; Lai M; de Hooge D; Canals M; de Esch IJ; Smit MJ; de Graaf C; Leurs R
Mol Pharmacol; 2014 Jan; 85(1):116-26. PubMed ID: 24174496
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and pharmacological evaluation of some 3-phenyl-2-substituted-3H-quinazolin-4-one as analgesic, anti-inflammatory agents.
Alagarsamy V; Raja Solomon V; Dhanabal K
Bioorg Med Chem; 2007 Jan; 15(1):235-41. PubMed ID: 17079148
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel 3-butyl-2-substituted amino-3H-quinazolin-4-ones as analgesic and anti-inflammatory agents.
Alagarsamy V; Meena S; Ramaseshu KV; Solomon VR; Kumar TD; Thirumurugan K
Chem Biol Drug Des; 2007 Sep; 70(3):254-60. PubMed ID: 17718720
[TBL] [Abstract][Full Text] [Related]
17. Short-acting 5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3H)-one derivatives as orally-active calcium-sensing receptor antagonists.
Didiuk MT; Griffith DA; Benbow JW; Liu KK; Walker DP; Bi FC; Morris J; Guzman-Perez A; Gao H; Bechle BM; Kelley RM; Yang X; Dirico K; Ahmed S; Hungerford W; DiBrinno J; Zawistoski MP; Bagley SW; Li J; Zeng Y; Santucci S; Oliver R; Corbett M; Olson T; Chen C; Li M; Paralkar VM; Riccardi KA; Healy DR; Kalgutkar AS; Maurer TS; Nguyen HT; Frederick KS
Bioorg Med Chem Lett; 2009 Aug; 19(16):4555-9. PubMed ID: 19625189
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 3-(2-pyridyl)-2-substituted-quinazolin-4(3H)-ones as new analgesic and anti-inflammatory agents.
Alagarsamy V; Solomon VR; Murugan M; Sankaranarayanan R; Periyasamy P; Deepa R; Anandkumar TD
Biomed Pharmacother; 2008 Sep; 62(7):454-61. PubMed ID: 17175131
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, analgesic, anti-inflammatory, ulcerogenic index and antibacterial activities of novel 2-methylthio-3-substituted-5,6,7,8-tetrahydrobenzo (b) thieno[2,3-d]pyrimidin-4(3H)-ones.
Alagarsamy V; Meena S; Ramseshu KV; Solomon VR; Thirumurugan K; Dhanabal K; Murugan M
Eur J Med Chem; 2006 Nov; 41(11):1293-300. PubMed ID: 16928409
[TBL] [Abstract][Full Text] [Related]
20. Design, new synthesis, and calcilytic activity of substituted 3H-pyrimidin-4-ones.
Shcherbakova I; Huang G; Geoffroy OJ; Nair SK; Swierczek K; Balandrin MF; Fox J; Heaton WL; Conklin RL
Bioorg Med Chem Lett; 2005 May; 15(10):2537-40. PubMed ID: 15863312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
